Clinical Trial Update: Essure (Model ESS310) Placement Rate Study [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update on Essure (ESS310) placement rate for contraception has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• Essure

Snippet

Sponsor: Bayer | Conditions: Contraception | Phase 3 | Status: COMPLETED